Initially used for type-2 diabetes management, GLP-1 RAs provide secondary benefits for weight loss, such as decreased appetite and slower digestion, which keeps patients full for longer, making it much easier to lose weight
thus, the preservation of this distribution likely contributed to the maintenance of muscle force
Log in $N/A (MSRP) Already have an account
This is the ideal time to establish your baseline measurements and monitoring routine
During your monthly check-ins, your provider will want to follow up on your progress so they can adjust the dosage of your medication accordingly
Automated Insulin Delivery ADA Only The ADA made sweeping changes to AID recommendations in 2026: AID is now the preferred insulin delivery method for all people with type 1 diabetes AID is preferred for adults and children with T2D on multiple daily injections, CSII, or sensor-augmented pump therapy AID should be offered to all adults with T1D or T2D on insulin AID can be considered in T2D on basal insulin who are not meeting glycemic goals No C-peptide level, islet autoantibody status, or insulin duration is required before starting CSII or AID Children and adolescents must be supported in device use at school
